135 related articles for article (PubMed ID: 38599123)
1. Single cell glycan-linkages profiling for hepatocellular carcinoma early diagnosis using lanthanide encoded bacteriophage MS2 based ICP-MS.
Liang Y; Liu Z; Zuo D; Chen S; Chen J; Yan X; Liu P; Wang Q
Talanta; 2024 Jul; 274():126056. PubMed ID: 38599123
[TBL] [Abstract][Full Text] [Related]
2. Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.
Zhu J; Warner E; Parikh ND; Lubman DM
Mass Spectrom Rev; 2019 May; 38(3):265-290. PubMed ID: 30472795
[TBL] [Abstract][Full Text] [Related]
3. LC-MS/MS isomeric profiling of permethylated N-glycans derived from serum haptoglobin of hepatocellular carcinoma (HCC) and cirrhotic patients.
Huang Y; Zhou S; Zhu J; Lubman DM; Mechref Y
Electrophoresis; 2017 Sep; 38(17):2160-2167. PubMed ID: 28543513
[TBL] [Abstract][Full Text] [Related]
4. High-resolution imaging and single-cell analysis via laser ablation-inductively coupled plasma-mass spectrometry for the determination of membranous receptor expression levels in breast cancer cell lines using receptor-specific hybrid tracers.
Van Acker T; Buckle T; Van Malderen SJM; van Willigen DM; van Unen V; van Leeuwen FWB; Vanhaecke F
Anal Chim Acta; 2019 Oct; 1074():43-53. PubMed ID: 31159938
[TBL] [Abstract][Full Text] [Related]
5. iTRAQ-coupled 2D LC-MS/MS analysis of secreted proteome of HBV-replicating HepG2 cells: potential in biomarkers for prognosis of HCC.
Feng H; Wang M; Chen WN
Curr Microbiol; 2010 Oct; 61(4):280-4. PubMed ID: 20165850
[TBL] [Abstract][Full Text] [Related]
6. An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma.
Kalinich M; Bhan I; Kwan TT; Miyamoto DT; Javaid S; LiCausi JA; Milner JD; Hong X; Goyal L; Sil S; Choz M; Ho U; Kapur R; Muzikansky A; Zhang H; Weitz DA; Sequist LV; Ryan DP; Chung RT; Zhu AX; Isselbacher KJ; Ting DT; Toner M; Maheswaran S; Haber DA
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1123-1128. PubMed ID: 28096363
[TBL] [Abstract][Full Text] [Related]
7. Detection of hepatocellular carcinoma in hepatitis C patients: biomarker discovery by LC-MS.
Bowers J; Hughes E; Skill N; Maluccio M; Raftery D
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():154-62. PubMed ID: 24666728
[TBL] [Abstract][Full Text] [Related]
8. N-glycan based models improve diagnostic efficacies in hepatitis B virus-related hepatocellular carcinoma.
Fang M; Zhao YP; Zhou FG; Lu LG; Qi P; Wang H; Zhou K; Sun SH; Chen CY; Gao CF
Int J Cancer; 2010 Jul; 127(1):148-59. PubMed ID: 19904744
[TBL] [Abstract][Full Text] [Related]
9. Novel biomarkers in hepatocellular carcinoma.
De Stefano F; Chacon E; Turcios L; Marti F; Gedaly R
Dig Liver Dis; 2018 Nov; 50(11):1115-1123. PubMed ID: 30217732
[TBL] [Abstract][Full Text] [Related]
10. Profiling of aberrant sialylated N-glycans in hepatocellular carcinoma by liquid chromatography mass spectrometry.
Zhu L; Zou S; Yao D; Li J; Xiong Y; Wu Q; Du Y; Wang J; Wu T; Wei B
Clin Chim Acta; 2024 Mar; 555():117827. PubMed ID: 38346531
[TBL] [Abstract][Full Text] [Related]
11. LC-MS profiling of N-Glycans derived from human serum samples for biomarker discovery in hepatocellular carcinoma.
Tsai TH; Wang M; Di Poto C; Hu Y; Zhou S; Zhao Y; Varghese RS; Luo Y; Tadesse MG; Ziada DH; Desai CS; Shetty K; Mechref Y; Ressom HW
J Proteome Res; 2014 Nov; 13(11):4859-68. PubMed ID: 25077556
[TBL] [Abstract][Full Text] [Related]
12. A Potential Serum
Higashi M; Yoshimura T; Usui N; Kano Y; Deguchi A; Tanabe K; Uchimura Y; Kuriyama S; Suzuki Y; Masaki T; Ikenaka K
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255418
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated carbohydrate antigens as potential biomarkers for hepatocellular carcinoma.
Wu CS; Yen CJ; Chou RH; Li ST; Huang WC; Ren CT; Wu CY; Yu YL
PLoS One; 2012; 7(7):e39466. PubMed ID: 22808038
[TBL] [Abstract][Full Text] [Related]
14. Changes in the Glycosylation of Kininogen and the Development of a Kininogen-Based Algorithm for the Early Detection of HCC.
Wang M; Sanda M; Comunale MA; Herrera H; Swindell C; Kono Y; Singal AG; Marrero J; Block T; Goldman R; Mehta A
Cancer Epidemiol Biomarkers Prev; 2017 May; 26(5):795-803. PubMed ID: 28223431
[No Abstract] [Full Text] [Related]
15. Extracellular mRNA detected by molecular beacons in tethered lipoplex nanoparticles for diagnosis of human hepatocellular carcinoma.
Wang X; Kwak KJ; Yang Z; Zhang A; Zhang X; Sullivan R; Lin D; Lee RL; Castro C; Ghoshal K; Schmidt C; Lee LJ
PLoS One; 2018; 13(6):e0198552. PubMed ID: 29879168
[TBL] [Abstract][Full Text] [Related]
16. N-glycan fingerprint predicts alpha-fetoprotein negative hepatocellular carcinoma: A large-scale multicenter study.
Huang C; Fang M; Feng H; Liu L; Li Y; Xu X; Wang H; Wang Y; Tong L; Zhou L; Gao C
Int J Cancer; 2021 Aug; 149(3):717-727. PubMed ID: 33729545
[TBL] [Abstract][Full Text] [Related]
17. A Predictive Model Using N-Glycan Biosignatures for Clinical Diagnosis of Early Hepatocellular Carcinoma Related to Hepatitis B Virus.
Cong M; Ou X; Huang J; Long J; Li T; Liu X; Wang Y; Wu X; Zhou J; Sun Y; Shang Q; Chen G; Ma H; Xie W; Piao H; Yang Y; Gao Z; Xu X; Tan Z; Chen C; Zeng N; Wu S; Kong Y; Liu T; Wang P; You H; Jia J; Zhuang H
OMICS; 2020 Jul; 24(7):415-423. PubMed ID: 32522092
[TBL] [Abstract][Full Text] [Related]
18. Development of a highly sensitive glycan microarray for quantifying AFP-L3 for early prediction of hepatitis B virus-related hepatocellular carcinoma.
Wu CS; Lee TY; Chou RH; Yen CJ; Huang WC; Wu CY; Yu YL
PLoS One; 2014; 9(6):e99959. PubMed ID: 24927126
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers for the early diagnosis of hepatocellular carcinoma.
Tsuchiya N; Sawada Y; Endo I; Saito K; Uemura Y; Nakatsura T
World J Gastroenterol; 2015 Oct; 21(37):10573-83. PubMed ID: 26457017
[TBL] [Abstract][Full Text] [Related]
20. Comparative Glycomics Study of Cell-Surface N-Glycomes of HepG2 versus LO2 Cell Lines.
Han Y; Xiao K; Tian Z
J Proteome Res; 2019 Jan; 18(1):372-379. PubMed ID: 30343578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
